CONCLUSION LEARNING POINTS
The treatment for FHH is mainly conservative as it is not known to lead to complications. Hence, making the appropriate diagnosis may avoid unnecessary parathyroid surgery.
With the presence of strong family history, this case emphasises the importance of investigating the calcium: creatinine clearance ratio and subsequent genetic testing for CASR mutations, (FHH panel and isolated familial hyperparathyroidism panel).
CASE HISTORY
A 60 year old Caucasian woman was referred to endocrine clinic with persistent hypercalcaemia between 2.8-2.9mmol/L (2.2-2.6), with inappropriately normal PTH at 7pmol/L (1.48-7.63). Her hypercalcaemia was noted first in 2008.
She had no signs or symptoms associated with hypercalcemia.
There was no history of pancreatitis.
Family History:
She has a strong family history of hypercalcaemia, where her mother required Cinacalcet to control her hypercalcaemia despite two previous parathyroid resections.
She has 3 children in their 30's who had not had calcium screening before. However, one of the son had a renal stone. Genetics laboratory has shown the variant to segregate with hypercalcaemia in two affected first-degree relatives in each family. This is consistent with the clinical presentation in this patient. Therefore, we seek to offer her first-degree relatives genetic counselling and screening.
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